Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.33 |
| ▸ | UCHL1 | P09936 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SCD | O00767 | 2/20 | 0.32 |
| ▸ | USP30 | Q70CQ3 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PTPRB | P23467 | 2/20 | 0.31 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.31 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
| ▸ | CFTR | P13569 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27583367 | 0.85 | KMT2A (0.41) | MEN1KMT2APAX8GSTO1UCHL1 | |
| SCHEMBL28302436 | 0.85 | MEN1 (0.40) | MEN1KMT2APAX8GSTO1UCHL1 | |
| SCHEMBL15709828 | 0.84 | MEN1 (0.46) | MEN1KMT2APAX8GSTO1UCHL1 | |
| SCHEMBL28302432 | 0.83 | MEN1 (0.45) | MEN1KMT2APAX8GSTO1UCHL1 | |
| SCHEMBL15709971 | 0.82 | MEN1 (0.50) | MEN1KMT2APAX8GAAMAPT | |
| SCHEMBL19820663 | 0.80 | MEN1 (0.68) | MEN1KMT2AGAAMAPTLMNA | |
| SCHEMBL23662174 | 0.79 | PAX8 (0.40) | MEN1KMT2APAX8GSTO1UCHL1 | |
| SCHEMBL31596356 | 0.77 | PAX8 (0.39) | MEN1KMT2APAX8GSTO1UCHL1 | |
| SCHEMBL6794653 | 0.77 | PSMD10 (0.35) | MEN1KMT2AMAPTLMNANPC1 | |
| SCHEMBL20387999 | 0.76 | MEN1 (0.40) | MEN1KMT2APAX8GSTO1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | MEN1 2426/4885KMT2A 2457/4885PAX8 4664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.